FEMASYS INC (FEMY) Fundamental Analysis & Valuation

NASDAQ:FEMY • US31447E1055

Current stock price

0.4102 USD
-0.01 (-1.61%)
At close:
0.42 USD
+0.01 (+2.39%)
After Hours:

This FEMY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. FEMY Profitability Analysis

1.1 Basic Checks

  • In the past year FEMY has reported negative net income.
  • FEMY had a negative operating cash flow in the past year.
  • FEMY had negative earnings in each of the past 5 years.
  • FEMY had a negative operating cash flow in each of the past 5 years.
FEMY Yearly Net Income VS EBIT VS OCF VS FCFFEMY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M -20M

1.2 Ratios

  • The Return On Assets of FEMY (-89.88%) is worse than 80.21% of its industry peers.
  • With a Return On Equity value of -317.38%, FEMY is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -89.88%
ROE -317.38%
ROIC N/A
ROA(3y)-97.47%
ROA(5y)-77.24%
ROE(3y)-403.85%
ROE(5y)-262.99%
ROIC(3y)N/A
ROIC(5y)N/A
FEMY Yearly ROA, ROE, ROICFEMY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600 -800

1.3 Margins

  • Looking at the Gross Margin, with a value of 61.96%, FEMY is in the better half of the industry, outperforming 64.71% of the companies in the same industry.
  • FEMY's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for FEMY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y-2.46%
FEMY Yearly Profit, Operating, Gross MarginsFEMY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. FEMY Health Analysis

2.1 Basic Checks

  • FEMY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, FEMY has more shares outstanding
  • The number of shares outstanding for FEMY has been increased compared to 5 years ago.
  • FEMY has a better debt/assets ratio than last year.
FEMY Yearly Shares OutstandingFEMY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
FEMY Yearly Total Debt VS Total AssetsFEMY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

2.2 Solvency

  • FEMY has an Altman-Z score of -10.43. This is a bad value and indicates that FEMY is not financially healthy and even has some risk of bankruptcy.
  • FEMY has a Altman-Z score of -10.43. This is amonst the worse of the industry: FEMY underperforms 80.75% of its industry peers.
  • A Debt/Equity ratio of 0.54 indicates that FEMY is somewhat dependend on debt financing.
  • FEMY has a worse Debt to Equity ratio (0.54) than 60.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF N/A
Altman-Z -10.43
ROIC/WACCN/A
WACC7.64%
FEMY Yearly LT Debt VS Equity VS FCFFEMY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M -20M

2.3 Liquidity

  • A Current Ratio of 4.53 indicates that FEMY has no problem at all paying its short term obligations.
  • FEMY has a Current ratio of 4.53. This is in the better half of the industry: FEMY outperforms 70.05% of its industry peers.
  • A Quick Ratio of 2.95 indicates that FEMY has no problem at all paying its short term obligations.
  • FEMY's Quick ratio of 2.95 is fine compared to the rest of the industry. FEMY outperforms 63.10% of its industry peers.
Industry RankSector Rank
Current Ratio 4.53
Quick Ratio 2.95
FEMY Yearly Current Assets VS Current LiabilitesFEMY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. FEMY Growth Analysis

3.1 Past

  • FEMY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.35%, which is quite impressive.
  • Looking at the last year, FEMY shows a very strong growth in Revenue. The Revenue has grown by 40.78%.
  • Measured over the past years, FEMY shows a quite strong growth in Revenue. The Revenue has been growing by 17.13% on average per year.
EPS 1Y (TTM)42.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.65%
Revenue 1Y (TTM)40.78%
Revenue growth 3Y23.75%
Revenue growth 5Y17.13%
Sales Q2Q%39.86%

3.2 Future

  • FEMY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.22% yearly.
  • Based on estimates for the next years, FEMY will show a very strong growth in Revenue. The Revenue will grow by 121.83% on average per year.
EPS Next Y28.18%
EPS Next 2Y19.63%
EPS Next 3Y21.15%
EPS Next 5Y27.22%
Revenue Next Year81.1%
Revenue Next 2Y133.18%
Revenue Next 3Y134.04%
Revenue Next 5Y121.83%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FEMY Yearly Revenue VS EstimatesFEMY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
FEMY Yearly EPS VS EstimatesFEMY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 -1 2

More info and screens

Find the best growth stocksShow best growing peers

1

4. FEMY Valuation Analysis

4.1 Price/Earnings Ratio

  • FEMY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year FEMY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FEMY Price Earnings VS Forward Price EarningsFEMY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FEMY Per share dataFEMY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3 -0.4

4.3 Compensation for Growth

  • FEMY's earnings are expected to grow with 21.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.63%
EPS Next 3Y21.15%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. FEMY Dividend Analysis

5.1 Amount

  • FEMY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

FEMY Fundamentals: All Metrics, Ratios and Statistics

FEMASYS INC

NASDAQ:FEMY (4/22/2026, 8:24:29 PM)

After market: 0.42 +0.01 (+2.39%)

0.4102

-0.01 (-1.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-31
Earnings (Next)05-07
Inst Owners10.26%
Inst Owner Change-0.05%
Ins Owners8.04%
Ins Owner Change0%
Market Cap24.77M
Revenue(TTM)2.29M
Net Income(TTM)-18.63M
Analysts82
Price Target4.34 (958.02%)
Short Float %3.72%
Short Ratio3.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)56.69%
Min EPS beat(2)24.59%
Max EPS beat(2)88.8%
EPS beat(4)3
Avg EPS beat(4)28.25%
Min EPS beat(4)-18.68%
Max EPS beat(4)88.8%
EPS beat(8)4
Avg EPS beat(8)8.37%
EPS beat(12)6
Avg EPS beat(12)5.02%
EPS beat(16)8
Avg EPS beat(16)4.17%
Revenue beat(2)0
Avg Revenue beat(2)-44.54%
Min Revenue beat(2)-50.71%
Max Revenue beat(2)-38.38%
Revenue beat(4)0
Avg Revenue beat(4)-53.73%
Min Revenue beat(4)-70.71%
Max Revenue beat(4)-38.38%
Revenue beat(8)0
Avg Revenue beat(8)-54.37%
Revenue beat(12)1
Avg Revenue beat(12)-38.53%
Revenue beat(16)2
Avg Revenue beat(16)-31.5%
PT rev (1m)-17.74%
PT rev (3m)-17.74%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)5.91%
EPS NY rev (3m)5.91%
Revenue NQ rev (1m)-70.74%
Revenue NQ rev (3m)-70.74%
Revenue NY rev (1m)-27.72%
Revenue NY rev (3m)-28.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.8
P/FCF N/A
P/OCF N/A
P/B 4.22
P/tB 4.32
EV/EBITDA N/A
EPS(TTM)-0.49
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS0.04
BVpS0.1
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -89.88%
ROE -317.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.96%
FCFM N/A
ROA(3y)-97.47%
ROA(5y)-77.24%
ROE(3y)-403.85%
ROE(5y)-262.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y-2.46%
F-Score2
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 184.24%
Cap/Sales 27.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.53
Quick Ratio 2.95
Altman-Z -10.43
F-Score2
WACC7.64%
ROIC/WACCN/A
Cap/Depr(3y)166.39%
Cap/Depr(5y)124.99%
Cap/Sales(3y)30.98%
Cap/Sales(5y)30.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.65%
EPS Next Y28.18%
EPS Next 2Y19.63%
EPS Next 3Y21.15%
EPS Next 5Y27.22%
Revenue 1Y (TTM)40.78%
Revenue growth 3Y23.75%
Revenue growth 5Y17.13%
Sales Q2Q%39.86%
Revenue Next Year81.1%
Revenue Next 2Y133.18%
Revenue Next 3Y134.04%
Revenue Next 5Y121.83%
EBIT growth 1Y1.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y4.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.87%
OCF growth 3YN/A
OCF growth 5YN/A

FEMASYS INC / FEMY Fundamental Analysis FAQ

What is the ChartMill fundamental rating of FEMASYS INC (FEMY) stock?

ChartMill assigns a fundamental rating of 3 / 10 to FEMY.


What is the valuation status of FEMASYS INC (FEMY) stock?

ChartMill assigns a valuation rating of 1 / 10 to FEMASYS INC (FEMY). This can be considered as Overvalued.


What is the profitability of FEMY stock?

FEMASYS INC (FEMY) has a profitability rating of 1 / 10.


How financially healthy is FEMASYS INC?

The financial health rating of FEMASYS INC (FEMY) is 3 / 10.